AASDH

Across TCGA pan-cancer cohorts, AASDH mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated AASDH data layer compared with 24 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher AASDH mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated AASDH expression acts as an unfavorable survival marker, although some lineages such as CCRCC and LSCC show a favorable association.

LUAD, CCRCC, and LSCC are the cancer types where AASDH mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Quartile	III,IV	0.345	0.875	.036	7	view →
CCRCC	OS	Median	All	1.000	0.769	.026	6	view →
LSCC	DFS	Tertile	III,IV	1.000	0.710	.042	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

AASDH–LUAD (DFS)

Open the LUAD breakdown →